NASDAQ: OPRX
Optimizerx Corp Stock

$8.45+0.27 (+3.3%)
Updated Apr 17, 2025
OPRX Price
$8.45
Fair Value Price
-$0.20
Market Cap
$156.24M
52 Week Low
$3.78
52 Week High
$14.13
P/E
-7.68x
P/B
1.34x
P/S
0.97x
PEG
N/A
Dividend Yield
N/A
Revenue
$92.13M
Earnings
-$20.11M
Gross Margin
64.5%
Operating Margin
-14.36%
Profit Margin
-21.8%
Debt to Equity
0.46
Operating Cash Flow
$5M
Beta
1.39
Next Earnings
May 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A

OPRX Overview

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine OPRX's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Health Information Service

Industry Rating
B
OPRX
Ranked
#10 of 44

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$149.00A
$62.37A
$1.42B
View Top Health Information Service Stocks

Be the first to know about important OPRX news, forecast changes, insider trades & much more!

OPRX News

Overview

Due Diligence Score

Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OPRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OPRX ($8.45) is overvalued by 4,288.86% relative to our estimate of its Fair Value price of -$0.20 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
OPRX ($8.45) is not significantly undervalued (4,288.86%) relative to our estimate of its Fair Value price of -$0.20 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
OPRX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OPRX due diligence checks available for Premium users.

Valuation

OPRX fair value

Fair Value of OPRX stock based on Discounted Cash Flow (DCF)

Price
$8.45
Fair Value
-$0.20
Undervalued by
4,288.86%
OPRX ($8.45) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OPRX ($8.45) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OPRX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OPRX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-7.68x
Industry
11.14x
Market
27.98x

OPRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.34x
Industry
3.39x
OPRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

OPRX's financial health

Profit margin

Revenue
$32.3M
Net Income
-$78.0k
Profit Margin
-0.2%
OPRX's Earnings (EBIT) of -$13.23M... subscribe to Premium to read more.
Interest Coverage Financials
OPRX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$171.2M
Liabilities
$54.2M
Debt to equity
0.46
OPRX's short-term assets ($53.97M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OPRX's short-term assets ($53.97M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OPRX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
OPRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$198.0k
Investing
-$120.0k
Financing
-$2.8M
OPRX's operating cash flow ($4.89M)... subscribe to Premium to read more.
Debt Coverage Financials

OPRX vs Health Information Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
OPRXB$156.24M+3.30%-7.68x1.34x
EUDAC$144.41M+1.51%-6.41x-23.98x
SOPHD$188.72M+0.71%-2.98x1.96x
AMWLC$108.96M-0.57%-0.50x0.36x
SY$82.79M+2.24%-1.05x0.33x

Optimizerx Stock FAQ

What is Optimizerx's quote symbol?

(NASDAQ: OPRX) Optimizerx trades on the NASDAQ under the ticker symbol OPRX. Optimizerx stock quotes can also be displayed as NASDAQ: OPRX.

If you're new to stock investing, here's how to buy Optimizerx stock.

What is the 52 week high and low for Optimizerx (NASDAQ: OPRX)?

(NASDAQ: OPRX) Optimizerx's 52-week high was $14.13, and its 52-week low was $3.78. It is currently -40.2% from its 52-week high and 123.54% from its 52-week low.

How much is Optimizerx stock worth today?

(NASDAQ: OPRX) Optimizerx currently has 18,490,385 outstanding shares. With Optimizerx stock trading at $8.45 per share, the total value of Optimizerx stock (market capitalization) is $156.24M.

Optimizerx stock was originally listed at a price of $10.40 in Jun 22, 2018. If you had invested in Optimizerx stock at $10.40, your return over the last 6 years would have been -18.75%, for an annualized return of -3.4% (not including any dividends or dividend reinvestments).

How much is Optimizerx's stock price per share?

(NASDAQ: OPRX) Optimizerx stock price per share is $8.45 today (as of Apr 17, 2025).

What is Optimizerx's Market Cap?

(NASDAQ: OPRX) Optimizerx's market cap is $156.24M, as of Apr 22, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Optimizerx's market cap is calculated by multiplying OPRX's current stock price of $8.45 by OPRX's total outstanding shares of 18,490,385.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.